"Global Molecular Diagnostics Market Overview:
Global Molecular Diagnostics Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Molecular Diagnostics Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Molecular Diagnostics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Molecular Diagnostics Market:
The Molecular Diagnostics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Molecular Diagnostics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Molecular Diagnostics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Molecular Diagnostics market has been segmented into:
Reagents & Kits
and Instruments
By Application, Molecular Diagnostics market has been segmented into:
Oncology
Genetic Testing
Microbiology
STDs
Blood Screening
Virology
Tissue Typing
Prenatal Diagnosis
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Molecular Diagnostics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Molecular Diagnostics market.
Top Key Players Covered in Molecular Diagnostics market are:
F. Hoffmann-La Roche Ltd
Illuminainc.
Hologicinc.
Agilent Technologies Inc.
Qiagen N.V.
Myriad Genetics
Becton
Dickinson and Company
Abbott Laboratories
bioMérieux SA
Bio-Rad Laboratoriesinc.
Sysmex Corporation
Danaher Corporation (Beckman Coulter Inc.)
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
Johnson & Johnson
Alere Inc.
Cepheid
Gen-Probe Incorporated
LabCorp (Monogram Biosciences)
STNovartis AG
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Molecular Diagnostics Market by Type
4.1 Molecular Diagnostics Market Snapshot and Growth Engine
4.2 Molecular Diagnostics Market Overview
4.3 Reagents & Kits
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Reagents & Kits: Geographic Segmentation Analysis
4.4 and Instruments
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 and Instruments: Geographic Segmentation Analysis
Chapter 5: Molecular Diagnostics Market by Application
5.1 Molecular Diagnostics Market Snapshot and Growth Engine
5.2 Molecular Diagnostics Market Overview
5.3 Oncology
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Oncology: Geographic Segmentation Analysis
5.4 Genetic Testing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Genetic Testing: Geographic Segmentation Analysis
5.5 Microbiology
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Microbiology: Geographic Segmentation Analysis
5.6 STDs
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 STDs: Geographic Segmentation Analysis
5.7 Blood Screening
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Blood Screening: Geographic Segmentation Analysis
5.8 Virology
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Virology: Geographic Segmentation Analysis
5.9 Tissue Typing
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Tissue Typing: Geographic Segmentation Analysis
5.10 Prenatal Diagnosis
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 Prenatal Diagnosis: Geographic Segmentation Analysis
5.11 and Others
5.11.1 Introduction and Market Overview
5.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.11.3 Key Market Trends, Growth Factors and Opportunities
5.11.4 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Molecular Diagnostics Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 F. HOFFMANN-LA ROCHE LTD
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ILLUMINAINC.
6.4 HOLOGICINC.
6.5 AGILENT TECHNOLOGIES INC.
6.6 QIAGEN N.V.
6.7 MYRIAD GENETICS
6.8 BECTON
6.9 DICKINSON AND COMPANY
6.10 ABBOTT LABORATORIES
6.11 BIOMÉRIEUX SA
6.12 BIO-RAD LABORATORIESINC.
6.13 SYSMEX CORPORATION
6.14 DANAHER CORPORATION (BECKMAN COULTER INC.)
6.15 THERMO FISHER SCIENTIFIC INC.
6.16 SIEMENS HEALTHINEERS AG
6.17 JOHNSON & JOHNSON
6.18 ALERE INC.
6.19 CEPHEID
6.20 GEN-PROBE INCORPORATED
6.21 LABCORP (MONOGRAM BIOSCIENCES)
6.22 AND STNOVARTIS AG
Chapter 7: Global Molecular Diagnostics Market By Region
7.1 Overview
7.2. North America Molecular Diagnostics Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Reagents & Kits
7.2.4.2 and Instruments
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Oncology
7.2.5.2 Genetic Testing
7.2.5.3 Microbiology
7.2.5.4 STDs
7.2.5.5 Blood Screening
7.2.5.6 Virology
7.2.5.7 Tissue Typing
7.2.5.8 Prenatal Diagnosis
7.2.5.9 and Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Molecular Diagnostics Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Reagents & Kits
7.3.4.2 and Instruments
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Oncology
7.3.5.2 Genetic Testing
7.3.5.3 Microbiology
7.3.5.4 STDs
7.3.5.5 Blood Screening
7.3.5.6 Virology
7.3.5.7 Tissue Typing
7.3.5.8 Prenatal Diagnosis
7.3.5.9 and Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Molecular Diagnostics Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Reagents & Kits
7.4.4.2 and Instruments
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Oncology
7.4.5.2 Genetic Testing
7.4.5.3 Microbiology
7.4.5.4 STDs
7.4.5.5 Blood Screening
7.4.5.6 Virology
7.4.5.7 Tissue Typing
7.4.5.8 Prenatal Diagnosis
7.4.5.9 and Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Molecular Diagnostics Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Reagents & Kits
7.5.4.2 and Instruments
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Oncology
7.5.5.2 Genetic Testing
7.5.5.3 Microbiology
7.5.5.4 STDs
7.5.5.5 Blood Screening
7.5.5.6 Virology
7.5.5.7 Tissue Typing
7.5.5.8 Prenatal Diagnosis
7.5.5.9 and Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Molecular Diagnostics Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Reagents & Kits
7.6.4.2 and Instruments
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Oncology
7.6.5.2 Genetic Testing
7.6.5.3 Microbiology
7.6.5.4 STDs
7.6.5.5 Blood Screening
7.6.5.6 Virology
7.6.5.7 Tissue Typing
7.6.5.8 Prenatal Diagnosis
7.6.5.9 and Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Molecular Diagnostics Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Reagents & Kits
7.7.4.2 and Instruments
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Oncology
7.7.5.2 Genetic Testing
7.7.5.3 Microbiology
7.7.5.4 STDs
7.7.5.5 Blood Screening
7.7.5.6 Virology
7.7.5.7 Tissue Typing
7.7.5.8 Prenatal Diagnosis
7.7.5.9 and Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Molecular Diagnostics Scope:
|
Report Data
|
Molecular Diagnostics Market
|
|
Molecular Diagnostics Market Size in 2025
|
USD XX million
|
|
Molecular Diagnostics CAGR 2025 - 2032
|
XX%
|
|
Molecular Diagnostics Base Year
|
2024
|
|
Molecular Diagnostics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
F. Hoffmann-La Roche Ltd, Illuminainc., Hologicinc., Agilent Technologies Inc., Qiagen N.V., Myriad Genetics, Becton, Dickinson and Company, Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratoriesinc., Sysmex Corporation, Danaher Corporation (Beckman Coulter Inc.), Thermo Fisher Scientific Inc., Siemens Healthineers AG, Johnson & Johnson, Alere Inc., Cepheid, Gen-Probe Incorporated, LabCorp (Monogram Biosciences), and STNovartis AG.
|
|
Key Segments
|
By Type
Reagents & Kits
and Instruments
By Applications
Oncology
Genetic Testing
Microbiology
STDs
Blood Screening
Virology
Tissue Typing
Prenatal Diagnosis
and Others
|
